Kircher, Tilo and Renate Thienel (2006). «Functional brain imaging of symptoms and cognition in schizophrenia». The Boundaries of Consciousness. Amsterdam: Elsevier. σελ. 302. ISBN0-444-52876-8.
Becker T, Kilian R (2006). «Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?». Acta Psychiatrica Scandinavica Supplement113 (429): 9–16. doi:10.1111/j.1600-0447.2005.00711.x. PMID16445476.
O'Donovan MC, Williams NM, Owen MJ (October 2003). «Recent advances in the genetics of schizophrenia». Hum. Mol. Genet.12 Spec No 2: R125–33. doi:10.1093/hmg/ddg302. PMID12952866.
McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W (January 2010). «Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies». Int. J. Drug Policy21 (1): 10–9. doi:10.1016/j.drugpo.2009.09.001. PMID19783132.
O'Donovan MC, Craddock NJ, Owen MJ (July 2009). «Genetics of psychosis; insights from views across the genome». Hum. Genet.126 (1): 3–12. doi:10.1007/s00439-009-0703-0. PMID19521722.
Crow TJ (July 2008). «The 'big bang' theory of the origin of psychosis and the faculty of language». Schizophrenia Research102 (1–3): 31–52. doi:10.1016/j.schres.2008.03.010. PMID18502103.
Selten JP, Cantor-Graae E, Kahn RS (March 2007). «Migration and schizophrenia». Current Opinion in Psychiatry20 (2): 111–115. doi:10.1097/YCO.0b013e328017f68e. PMID17278906.
Broome MR, Woolley JB, Tabraham P, et al. (November 2005). «What causes the onset of psychosis?». Schizophr. Res.79 (1): 23–34. doi:10.1016/j.schres.2005.02.007. PMID16198238.
Kurtz MM (2005). «Neurocognitive impairment across the lifespan in schizophrenia: an update». Schizophrenia Research74 (1): 15–26. doi:10.1016/j.schres.2004.07.005. PMID15694750.
Cohen AS, Docherty NM (2004). «Affective reactivity of speech and emotional experience in patients with schizophrenia». Schizophrenia Research69 (1): 7–14. doi:10.1016/S0920-9964(03)00069-0. PMID15145465.
Horan WP, Blanchard JJ (2003). «Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping». Schizophrenia Research60 (2–3): 271–83. doi:10.1016/S0920-9964(02)00227-X. PMID12591589.
Smith B, Fowler DG, Freeman D, et al. (September 2006). «Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations». Schizophr. Res.86 (1–3): 181–8. doi:10.1016/j.schres.2006.06.018. PMID16857346.
Beck, AT (2004). «A Cognitive Model of Schizophrenia». Journal of Cognitive Psychotherapy18 (3): 281–88. doi:10.1891/jcop.18.3.281.65649.
Bell V, Halligan PW, Ellis HD (2006). «Explaining delusions: a cognitive perspective». Trends in Cognitive Science10 (5): 219–26. doi:10.1016/j.tics.2006.03.004. PMID16600666.
Green MF (2006). «Cognitive impairment and functional outcome in schizophrenia and bipolar disorder». Journal of Clinical Psychiatry67 (Suppl 9): 3–8. doi:10.4088/jcp.1006e12. PMID16965182.
Jones HM, Pilowsky LS (2002). «Dopamine and antipsychotic drug action revisited». British Journal of Psychiatry181: 271–275. doi:10.1192/bjp.181.4.271. PMID12356650.
Konradi C, Heckers S (2003). «Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment». Pharmacology and Therapeutics97 (2): 153–79. doi:10.1016/S0163-7258(02)00328-5. PMID12559388.
Jakobsen KD, Frederiksen JN, Hansen T, et al. (2005). «Reliability of clinical ICD-10 schizophrenia diagnoses». Nordic Journal of Psychiatry59 (3): 209–12. doi:10.1080/08039480510027698. PMID16195122.
Tandon R, Gaebel W, Barch DM, et al. (October 2013). «Definition and description of schizophrenia in the DSM-5». Schizophr. Res.150 (1): 3–10. doi:10.1016/j.schres.2013.05.028. PMID23800613.
Barch DM, Bustillo J, Gaebel W, et al. (October 2013). «Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5». Schizophr. Res.150 (1): 15–20. doi:10.1016/j.schres.2013.04.027. PMID23706415.
McGlashan TH (February 1987). «Testing DSM-III symptom criteria for schizotypal and borderline personality disorders». Archives of General Psychiatry44 (2): 143–8. doi:10.1001/archpsyc.1987.01800140045007. PMID3813809.
Marshall, M; Rathbone, J (Jun 15, 2011). «Early intervention for psychosis.». The Cochrane database of systematic reviews (6): CD004718. doi:10.1002/14651858.CD004718.pub3. PMID21678345.
de Koning MB, Bloemen OJ, van Amelsvoort TA, et al. (June 2009). «Early intervention in patients at ultra high risk of psychosis: benefits and risks». Acta Psychiatr Scand119 (6): 426–42. doi:10.1111/j.1600-0447.2009.01372.x. PMID19392813.
Hartling L, Abou-Setta AM, Dursun S, et al. (14 August 2012). «Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-generation versus second-generation medications: a systematic review and meta-analysis». Annals of Internal Medicine157 (7): 498–511. doi:10.7326/0003-4819-157-7-201210020-00525. PMID22893011.
Taylor DM (2000). «Refractory schizophrenia and atypical antipsychotics». J Psychopharmacol14 (4): 409–418. doi:10.1177/026988110001400411.
Essali A, Al-Haj Haasan N, Li C, Rathbone J (2009). «Clozapine versus typical neuroleptic medication for schizophrenia». Cochrane Database of Systematic Reviews (1): CD000059. doi:10.1002/14651858.CD000059.pub2. PMID19160174.
Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T (April 2004). «Neuroleptic malignant syndrome and atypical antipsychotic drugs». Journal of Clinical Psychiatry65 (4): 464–70. doi:10.4088/JCP.v65n0403. PMID15119907.
Pharoah F, Mari J, Rathbone J, Wong W (2010). «Family intervention for schizophrenia». Cochrane Database of Systematic Reviews12 (12): CD000088. doi:10.1002/14651858.CD000088.pub3. PMID21154340.
Jauhar S, McKenna PJ, Radua J, et al. (January 2014). «Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias». The British journal of psychiatry : the journal of mental science204 (1): 20–9. doi:10.1192/bjp.bp.112.116285. PMID24385461.
Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C (2004). «Cognitive behaviour therapy for schizophrenia». Cochrane Database of Systematic Reviews (4): CD000524. doi:10.1002/14651858.CD000524.pub2. PMID15495000.
Laursen TM, Munk-Olsen T, Vestergaard, M (March 2012). «Life expectancy and cardiovascular mortality in persons with schizophrenia». Current opinion in psychiatry25 (2): 83–8. doi:10.1097/YCO.0b013e32835035ca. PMID22249081.
Erlangsen, A; Eaton, WW; Mortensen, PB; Conwell, Y (Feb 2012). «Schizophrenia--a predictor of suicide during the second half of life?». Schizophrenia research134 (2-3): 111–7. doi:10.1016/j.schres.2011.09.032. PMID22018943.
Saha S, Chant D, McGrath J (October 2007). «A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?». Arch. Gen. Psychiatry64 (10): 1123–31. doi:10.1001/archpsyc.64.10.1123. PMID17909124.
Ustun TB, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J, και ο WHO/National Institutes of Health (1999). «Multiple-informant ranking of the disabling effects of different health conditions in 14 countries». The Lancet354 (9173): 111–15. doi:10.1016/S0140-6736(98)07507-2. PMID10408486.
Burns J (August 2009). «Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia». Afr J Psychiatry (Johannesbg)12 (3): 200–5. doi:10.4314/ajpsy.v12i3.48494. PMID19894340.
Palmer BA, Pankratz VS, Bostwick JM (March 2005). «The lifetime risk of suicide in schizophrenia: a reexamination». Archives of General Psychiatry62 (3): 247–53. doi:10.1001/archpsyc.62.3.247. PMID15753237.
Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P (July 2010). «Suicide in schizophrenia». Expert Rev Neurother10 (7): 1153–64. doi:10.1586/ern.10.82. PMID20586695.
De Leon J, Diaz FJ (2005). «A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors». Schizophrenia research76 (2-3): 135–57. doi:10.1016/j.schres.2005.02.010. PMID15949648.
Cascio MT, Cella M, Preti A, Meneghelli A, Cocchi A (May 2012). «Gender and duration of untreated psychosis: a systematic review and meta-analysis». Early intervention in psychiatry6 (2): 115–27. doi:10.1111/j.1751-7893.2012.00351.x. PMID22380467.
Jablensky A, Sartorius N, Ernberg G, et al. (1992). «Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study». Psychological Medicine Monograph Supplement20: 1–97. doi:10.1017/S0264180100000904. PMID1565705.
Kirkbride JB, Fearon P, Morgan C, et al. (March 2006). «Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study». Archives of General Psychiatry63 (3): 250–8. doi:10.1001/archpsyc.63.3.250. PMID16520429.
Kirkbride JB, Fearon P, Morgan C, et al. (2007). «Neighbourhood variation in the incidence of psychotic disorders in Southeast London». Social Psychiatry and Psychiatric Epidemiology42 (6): 438–45. doi:10.1007/s00127-007-0193-0. PMID17473901.
Becker T, Kilian R (2006). «Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?». Acta Psychiatrica Scandinavica Supplement113 (429): 9–16. doi:10.1111/j.1600-0447.2005.00711.x. PMID16445476.
O'Donovan MC, Williams NM, Owen MJ (October 2003). «Recent advances in the genetics of schizophrenia». Hum. Mol. Genet.12 Spec No 2: R125–33. doi:10.1093/hmg/ddg302. PMID12952866.
McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W (January 2010). «Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies». Int. J. Drug Policy21 (1): 10–9. doi:10.1016/j.drugpo.2009.09.001. PMID19783132.
O'Donovan MC, Craddock NJ, Owen MJ (July 2009). «Genetics of psychosis; insights from views across the genome». Hum. Genet.126 (1): 3–12. doi:10.1007/s00439-009-0703-0. PMID19521722.
Crow TJ (July 2008). «The 'big bang' theory of the origin of psychosis and the faculty of language». Schizophrenia Research102 (1–3): 31–52. doi:10.1016/j.schres.2008.03.010. PMID18502103.
Selten JP, Cantor-Graae E, Kahn RS (March 2007). «Migration and schizophrenia». Current Opinion in Psychiatry20 (2): 111–115. doi:10.1097/YCO.0b013e328017f68e. PMID17278906.
Kurtz MM (2005). «Neurocognitive impairment across the lifespan in schizophrenia: an update». Schizophrenia Research74 (1): 15–26. doi:10.1016/j.schres.2004.07.005. PMID15694750.
Cohen AS, Docherty NM (2004). «Affective reactivity of speech and emotional experience in patients with schizophrenia». Schizophrenia Research69 (1): 7–14. doi:10.1016/S0920-9964(03)00069-0. PMID15145465.
Horan WP, Blanchard JJ (2003). «Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping». Schizophrenia Research60 (2–3): 271–83. doi:10.1016/S0920-9964(02)00227-X. PMID12591589.
Smith B, Fowler DG, Freeman D, et al. (September 2006). «Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations». Schizophr. Res.86 (1–3): 181–8. doi:10.1016/j.schres.2006.06.018. PMID16857346.
Bell V, Halligan PW, Ellis HD (2006). «Explaining delusions: a cognitive perspective». Trends in Cognitive Science10 (5): 219–26. doi:10.1016/j.tics.2006.03.004. PMID16600666.
Green MF (2006). «Cognitive impairment and functional outcome in schizophrenia and bipolar disorder». Journal of Clinical Psychiatry67 (Suppl 9): 3–8. doi:10.4088/jcp.1006e12. PMID16965182.
Jones HM, Pilowsky LS (2002). «Dopamine and antipsychotic drug action revisited». British Journal of Psychiatry181: 271–275. doi:10.1192/bjp.181.4.271. PMID12356650.
Konradi C, Heckers S (2003). «Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment». Pharmacology and Therapeutics97 (2): 153–79. doi:10.1016/S0163-7258(02)00328-5. PMID12559388.
Jakobsen KD, Frederiksen JN, Hansen T, et al. (2005). «Reliability of clinical ICD-10 schizophrenia diagnoses». Nordic Journal of Psychiatry59 (3): 209–12. doi:10.1080/08039480510027698. PMID16195122.
Tandon R, Gaebel W, Barch DM, et al. (October 2013). «Definition and description of schizophrenia in the DSM-5». Schizophr. Res.150 (1): 3–10. doi:10.1016/j.schres.2013.05.028. PMID23800613.
Barch DM, Bustillo J, Gaebel W, et al. (October 2013). «Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5». Schizophr. Res.150 (1): 15–20. doi:10.1016/j.schres.2013.04.027. PMID23706415.
McGlashan TH (February 1987). «Testing DSM-III symptom criteria for schizotypal and borderline personality disorders». Archives of General Psychiatry44 (2): 143–8. doi:10.1001/archpsyc.1987.01800140045007. PMID3813809.
Marshall, M; Rathbone, J (Jun 15, 2011). «Early intervention for psychosis.». The Cochrane database of systematic reviews (6): CD004718. doi:10.1002/14651858.CD004718.pub3. PMID21678345.
de Koning MB, Bloemen OJ, van Amelsvoort TA, et al. (June 2009). «Early intervention in patients at ultra high risk of psychosis: benefits and risks». Acta Psychiatr Scand119 (6): 426–42. doi:10.1111/j.1600-0447.2009.01372.x. PMID19392813.
Hartling L, Abou-Setta AM, Dursun S, et al. (14 August 2012). «Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-generation versus second-generation medications: a systematic review and meta-analysis». Annals of Internal Medicine157 (7): 498–511. doi:10.7326/0003-4819-157-7-201210020-00525. PMID22893011.
Smith T, Weston C, Lieberman J (August 2010). «Schizophrenia (maintenance treatment)». Am Fam Physician82 (4): 338–9. PMID20704164.
Essali A, Al-Haj Haasan N, Li C, Rathbone J (2009). «Clozapine versus typical neuroleptic medication for schizophrenia». Cochrane Database of Systematic Reviews (1): CD000059. doi:10.1002/14651858.CD000059.pub2. PMID19160174.
Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T (April 2004). «Neuroleptic malignant syndrome and atypical antipsychotic drugs». Journal of Clinical Psychiatry65 (4): 464–70. doi:10.4088/JCP.v65n0403. PMID15119907.
McEvoy JP (2006). «Risks versus benefits of different types of long-acting injectable antipsychotics». J Clin Psychiatry67 Suppl 5: 15–8. PMID16822092.
Pharoah F, Mari J, Rathbone J, Wong W (2010). «Family intervention for schizophrenia». Cochrane Database of Systematic Reviews12 (12): CD000088. doi:10.1002/14651858.CD000088.pub3. PMID21154340.
Jauhar S, McKenna PJ, Radua J, et al. (January 2014). «Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias». The British journal of psychiatry : the journal of mental science204 (1): 20–9. doi:10.1192/bjp.bp.112.116285. PMID24385461.
Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C (2004). «Cognitive behaviour therapy for schizophrenia». Cochrane Database of Systematic Reviews (4): CD000524. doi:10.1002/14651858.CD000524.pub2. PMID15495000.
Laursen TM, Munk-Olsen T, Vestergaard, M (March 2012). «Life expectancy and cardiovascular mortality in persons with schizophrenia». Current opinion in psychiatry25 (2): 83–8. doi:10.1097/YCO.0b013e32835035ca. PMID22249081.
Erlangsen, A; Eaton, WW; Mortensen, PB; Conwell, Y (Feb 2012). «Schizophrenia--a predictor of suicide during the second half of life?». Schizophrenia research134 (2-3): 111–7. doi:10.1016/j.schres.2011.09.032. PMID22018943.
Saha S, Chant D, McGrath J (October 2007). «A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?». Arch. Gen. Psychiatry64 (10): 1123–31. doi:10.1001/archpsyc.64.10.1123. PMID17909124.
Ustun TB, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J, και ο WHO/National Institutes of Health (1999). «Multiple-informant ranking of the disabling effects of different health conditions in 14 countries». The Lancet354 (9173): 111–15. doi:10.1016/S0140-6736(98)07507-2. PMID10408486.
Isaac M, Chand P, Murthy P (August 2007). «Schizophrenia outcome measures in the wider international community». Br J Psychiatry Suppl50: s71–7. PMID18019048.
Burns J (August 2009). «Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia». Afr J Psychiatry (Johannesbg)12 (3): 200–5. doi:10.4314/ajpsy.v12i3.48494. PMID19894340.
Palmer BA, Pankratz VS, Bostwick JM (March 2005). «The lifetime risk of suicide in schizophrenia: a reexamination». Archives of General Psychiatry62 (3): 247–53. doi:10.1001/archpsyc.62.3.247. PMID15753237.
Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P (July 2010). «Suicide in schizophrenia». Expert Rev Neurother10 (7): 1153–64. doi:10.1586/ern.10.82. PMID20586695.
De Leon J, Diaz FJ (2005). «A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors». Schizophrenia research76 (2-3): 135–57. doi:10.1016/j.schres.2005.02.010. PMID15949648.
Cascio MT, Cella M, Preti A, Meneghelli A, Cocchi A (May 2012). «Gender and duration of untreated psychosis: a systematic review and meta-analysis». Early intervention in psychiatry6 (2): 115–27. doi:10.1111/j.1751-7893.2012.00351.x. PMID22380467.
Jablensky A, Sartorius N, Ernberg G, et al. (1992). «Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study». Psychological Medicine Monograph Supplement20: 1–97. doi:10.1017/S0264180100000904. PMID1565705.
Kirkbride JB, Fearon P, Morgan C, et al. (March 2006). «Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study». Archives of General Psychiatry63 (3): 250–8. doi:10.1001/archpsyc.63.3.250. PMID16520429.
Kirkbride JB, Fearon P, Morgan C, et al. (2007). «Neighbourhood variation in the incidence of psychotic disorders in Southeast London». Social Psychiatry and Psychiatric Epidemiology42 (6): 438–45. doi:10.1007/s00127-007-0193-0. PMID17473901.
«THE ABANDONED ILLNESS»(PDF). Schizophrenia Commission. Νοε 2012. σελ. 10. Αρχειοθετήθηκε από το πρωτότυπο(PDF) στις 24 Φεβρουαρίου 2015. Ανακτήθηκε στις 19 Απριλίου 2014.
«THE ABANDONED ILLNESS»(PDF). Schizophrenia Commission. Νοε 2012. σελ. 10. Αρχειοθετήθηκε από το πρωτότυπο(PDF) στις 24 Φεβρουαρίου 2015. Ανακτήθηκε στις 19 Απριλίου 2014.